Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Dermatologic 1

Conditions

Melanoma 3Squamous Cell Carcinoma of Head and Neck 1Skin Neoplasms 1Sarcoma, Kaposi 1HIV Infections 1Acquired Immunodeficiency Syndrome 1

Interventions

Specimen Handling 2Semaxinib 2Magnetic Resonance Spectroscopy 2tin etiopurpurin 1pembrolizumab 1fludarabine phosphate 1cabozantinib 1Whole-Body Irradiation 1Tumor Necrosis Factor-alpha 1Sunitinib 1Ritonavir 1Peripheral Blood Stem Cell Transplantation 1Nivolumab 1Nelfinavir 1Mycophenolic Acid 1Cyclosporine 1Biopsy 1Antiretroviral Therapy, Highly Active 14,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
HIV Infections × Tumor Necrosis Factor-alpha × Dermatologic × Clear all
NCT00002262 2005-06-24

A Phase I/II Study of Intralesional Recombinant Tumor Necrosis Factor in Patients With AIDS-Related Cutaneous Kaposi's Sarcoma

NIH AIDS Clinical Trials Information Service

Phase 1 Completed
DermatologicSarcoma

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, Skin Neoplasms, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡